Literature DB >> 6097177

In vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum orbiculare.

J Faergemann.   

Abstract

The MICs of ketoconazole and itraconazole against Pityrosporum orbiculare were 0.02 to 0.05 and 0.1 to 0.2 micrograms ml-1, respectively. In a rabbit model, orally administered ketoconazole (1 mg kg-1) afforded protection against experimental pityriasis (tinea) versicolor in all animals. Itraconazole (5 mg kg-1) was effective in four of five rabbits.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6097177      PMCID： PMC180012          DOI： 10.1128/AAC.26.5.773

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles.

Authors:  H Van den Bossche; G Willemsens; W Cools; P Marichal; W Lauwers
Journal:  Biochem Soc Trans       Date:  1983-12       Impact factor: 5.407

Review 2.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

3.  Tinea versicolor: treatment and prophylaxis with ketoconazole.

Authors:  J Faergemann; L Djärv
Journal:  Cutis       Date:  1982-10

4.  The activity in vitro of five different antimycotics against Pityrosporum orbiculare.

Authors:  J Faergemann; S Bernander
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

5.  The antimycotic activity in vitro of five diols.

Authors:  J Faergemann; T Fredriksson
Journal:  Sabouraudia       Date:  1980-12

6.  Experimental infections in rabbits and humans with Pityrosporum orbiculare and P. ovale.

Authors:  J Faergemann; T Fredriksson
Journal:  J Invest Dermatol       Date:  1981-09       Impact factor: 8.551

7.  Experimental tinea versicolor in rabbits and humans with Pityrosporum orbiculare.

Authors:  J Faergemann
Journal:  J Invest Dermatol       Date:  1979-06       Impact factor: 8.551
  7 in total
  9 in total

Review 1.  Malassezia (pityrosporum) folliculitis.

Authors:  Richard M Rubenstein; Sarah A Malerich
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

Review 2.  The control of seborrhoeic dermatitis and dandruff by antipityrosporal drugs.

Authors:  J McGrath; G M Murphy
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

Review 3.  Human infections due to Malassezia spp.

Authors:  M J Marcon; D A Powell
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

4.  In vitro activity of systemic antifungal agents against Malassezia furfur.

Authors:  M J Marcon; D E Durrell; D A Powell; W J Buesching
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

5.  A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.

Authors:  S Rincón; M C Cepero de García; A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  Antifungal activity of ketoconazole and other azoles against Malassezia furfur in vitro and in vivo.

Authors:  V Strippoli; A Piacentini; F D D'Auria; N Simonetti
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

7.  In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.

Authors:  Margarita Garau; Manolo Pereiro; Amalia del Palacio
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  A study to evaluate the price control of antifungal medicines and its practical applicability.

Authors:  Amrita Sil; Nilay Kanti Das; Pramit Ghosh; Pijush Kanti Datta; Chowdhury Nazrul Islam; Santanu Kumar Tripathi
Journal:  Indian J Pharmacol       Date:  2012 Nov-Dec       Impact factor: 1.200

9.  In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.

Authors:  Sara Teixeira de Macedo-Silva; Julio A Urbina; Wanderley de Souza; Juliany Cola Fernandes Rodrigues
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.